What is the relationship between tumor differentiation and malignancy?
Tumor differentiation is closely related to malignancy, with general correlations including: well-differentiated tumors having low malignancy, moderately differentiated tumors having intermediate malignancy, poorly differentiated tumors having high malignancy, undifferentiated tumors having very high malignancy, and differentiation level influencing prognosis assessment. Detailed analysis is as follows:

1. Well-differentiated tumors have low malignancy: The cells are morphologically and functionally close to normal cells, grow slowly, have weak metastatic potential, progress gradually, rarely recur after treatment, and cause minimal harm to the body.
2. Moderately differentiated tumors have intermediate malignancy: Differentiation lies between well- and poorly-differentiated types. Cells show noticeable differences from normal cells, with moderate growth rate, metastasis potential, and disease progression. Treatment difficulty and prognosis are also intermediate.
3. Poorly differentiated tumors have high malignancy: Cells differ significantly from normal cells in morphology and function, grow rapidly, easily metastasize, progress quickly, carry a high risk of recurrence after treatment, pose substantial health risks, and are more difficult to treat.
4. Undifferentiated tumors have very high malignancy: Cells completely lose normal structure and function, making their origin difficult to identify. They exhibit strong invasive and proliferative capacity, rapidly metastasize within a short period, respond poorly to treatment, have unfavorable prognosis, and pose severe threats to life.
5. Differentiation level affects prognosis assessment: It is an important indicator for predicting outcomes. Well-differentiated tumors generally have good prognosis, while poorly and undifferentiated tumors have poor prognosis. Clinicians use this information to formulate treatment plans and evaluate therapeutic response and recurrence risk.
After tumor diagnosis, it is essential to promptly determine the degree of differentiation to guide treatment decisions; follow medical advice for standardized therapy to avoid delays; and undergo regular follow-up examinations after treatment to monitor disease status.